ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Immunic, Inc. - Common Stock (NQ:IMUX)

1.320 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 25, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	711
Open	1.320
Bid (Size)	1.290 (100)
Ask (Size)	1.350 (3,000)
Prev. Close	1.320
Today's Range	1.320 - 1.320
52wk Range	0.5062 - 1.510
Shares Outstanding	26,249,439
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Stock Market Today, March 24: Oil, AI, and Private Credit Fears Weigh on Markets ↗

March 24, 2026

On March 24, 2026, choppy, oil-driven trading and fresh AI disruption fears pressured major U.S. indexes.

Via The Motley Fool

Which stocks have an unusual volume on Tuesday? ↗

February 17, 2026

Via Chartmill

Performance

YTD	+126.4%	+126.4%
1 Month	+52.5%	+52.5%
3 Month	+125.9%	+125.9%
6 Month	+50.2%	+50.2%
1 Year	+5.6%	+5.6%

More News

Immunic Stock Jumps After Pricing $400 Million Private Placement ↗

February 13, 2026

Via Benzinga

Traders are paying attention to the gapping stocks in Friday's session. ↗

February 13, 2026

Via Chartmill

What's going on in today's pre-market session ↗

February 13, 2026

Via Chartmill

Why Did IMUX Stock Surge 33% Pre-Market Today? ↗

February 13, 2026

Via Stocktwits

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 18, 2025

Via Benzinga

This Electronic Arts Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗

September 29, 2025

Via Benzinga

This VSE Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

September 29, 2025

Via Benzinga

Immunic (IMUX) Q2 Loss Widens 25% ↗

August 07, 2025

Via The Motley Fool

Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial ↗

July 07, 2025

Via Stocktwits

Immunic to Participate in Scientific and Industry Conferences in May ↗

July 07, 2025

Via Stocktwits

Immunic, Inc. Announces Proposed Public Offering ↗

July 07, 2025

Via Stocktwits

Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering ↗

July 07, 2025

Via Stocktwits

Immunic to Participate in Investor, Scientific and Industry Conferences in June ↗

July 02, 2025

Via Stocktwits

Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering ↗

July 02, 2025

Via Stocktwits

Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS ↗

July 02, 2025

Via Stocktwits

Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis ↗

July 02, 2025

Via Stocktwits

Let's take a look at the stocks that are in motion in today's session. ↗

May 29, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 28, 2025

Via Benzinga

Wednesday's session: top gainers and losers ↗

April 30, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 30, 2025

Via Benzinga

Wednesday's session: gap up and gap down stocks ↗

April 30, 2025

Via Chartmill

These stocks that are showing activity before the opening bell on Wednesday. ↗

April 30, 2025

Via Chartmill

Frequently Asked Questions

Is Immunic, Inc. - Common Stock publicly traded?

Yes, Immunic, Inc. - Common Stock is publicly traded.

What exchange does Immunic, Inc. - Common Stock trade on?

Immunic, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Immunic, Inc. - Common Stock?

The ticker symbol for Immunic, Inc. - Common Stock is IMUX on the Nasdaq Stock Market

What is the current price of Immunic, Inc. - Common Stock?

The current price of Immunic, Inc. - Common Stock is 1.320

When was Immunic, Inc. - Common Stock last traded?

The last trade of Immunic, Inc. - Common Stock was at 03/25/26 04:00 PM ET

What is the market capitalization of Immunic, Inc. - Common Stock?

The market capitalization of Immunic, Inc. - Common Stock is 34.65M

How many shares of Immunic, Inc. - Common Stock are outstanding?

Immunic, Inc. - Common Stock has 35M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.